Current Medicines
For more than 145 years, we have worked tirelessly to develop and deliver trusted medicines and diagnostics that meet real needs. Our growing portfolio of medicines includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neuroscience and obesity.
The product information on this website is intended for residents of the United States.
If you are a customer and have questions regarding Lilly medicines, please call The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979).
Glyxambi, Jardiance, Jentadueto, Jentadueto XR, Synjardy, Synjardy XR, Tradjenta and Trijardy XR are registered trademarks of Boehringer Ingelheim International GmbH and are used under license.
Basaglar, Glyxambi, Jardiance, Jentadueto, Jentadueto XR, Synjardy, Synjardy XR, Tradjenta and Trijardy XR are part of the Boehringer Ingelheim–Lilly Alliance.